The Current Ratio as of December 2025 (TTM) for Sprint Bioscience AB (publ) (SPRINT.ST) is 1.13

According to Sprint Bioscience AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 1.13. This represents a change of -2.60% compared to the average of 1.16 of the last 4 quarters.

Sprint Bioscience AB (publ) (SPRINT.ST) Historical Current Ratio (quarterly & annually)

How has SPRINT.ST Current Ratio performed in the past?

The mean historical Current Ratio of Sprint Bioscience AB (publ) over the last ten years is 2.21. The current 1.13 Current Ratio has changed 5.02% with respect to the historical average. Over the past ten years (40 quarters), SPRINT.ST's Current Ratio was at its highest in in the September 2021 quarter at 9.29. The Current Ratio was at its lowest in in the June 2020 quarter at 0.50.

Sprint Bioscience AB (publ) (SPRINT.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sprint Bioscience AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sprint Bioscience AB (publ) (SPRINT.ST) Average Current Ratio

How has SPRINT.ST Current Ratio performed in the past?

The current Current Ratio of Sprint Bioscience AB (publ) (SPRINT.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sprint Bioscience AB (publ) (SPRINT.ST) Current Ratio vs. Peers

How is SPRINT.ST’s Current Ratio compared to its peers?

Sprint Bioscience AB (publ)’s Current Ratio is less than Spago Nanomedical AB (publ) (3.95), greater than Alligator Bioscience AB (publ) (0.56), less than AcouSort AB (publ) (4.27), less than SpectraCure AB (publ) (3.15), greater than Pila Pharma AB (publ) (0.95), less than Lipigon Pharmaceuticals AB (publ) (5.95), greater than Simris Alg AB (publ) (0.17), less than Active Biotech AB (publ) (1.17), less than OncoZenge AB (publ) (4.28), less than IDL Diagnostics AB (publ) (3.65),

Build a custom stock screener for Sprint Bioscience AB (publ) (SPRINT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sprint Bioscience AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sprint Bioscience AB (publ) (SPRINT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sprint Bioscience AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.